genetic-testing

A proof-of-concept bioinformatics platform designed to translate complex genomic reports into clear, patient-friendly clinical interpretations, bridging computational genomics with accessible healthcare communication and supporting more understandable interpretation of genomic information.

A platform that enables the visualization of individual genes for evidence of reannotation.

GeneClaw help users take advantage of the wealth of valuable information patients get from a genetic test result.

Virtual gene panel integration for Parkinson's Disease. This workflow collects, filters, and enriches gene panels with genomic features from NCBI, producing ready-to-use BED files.

Invitae (now Labcorp Invitae, following Labcorp's 2024 acquisition of select Invitae assets) is a United States medical genetics and healthcare-technology company that provides clinical-grade hereditary and somatic genetic testing across oncology, women's health, cardiology, neurology, pediatrics, and rare disease.

Natera is a clinical genetic testing company spanning women's health, oncology, and organ health. Rather than a public developer REST API, Natera exposes integration surfaces - Epic Aura bidirectional order/results, OncoEMR (Flatiron) and other EHR connectivity over HL7, the Constellation cloud bioinformatics platform for partner labs, and…

NCBI Medical Genetics, UMLS Unified Medical Language System Concepts and PubMed linked citations

HealthGeneTech (HGT) is a genomics company focused on gene fragment analysis and the development of applications for genetic testing and diagnostics. It is a healthcare portfolio company of Qiming Venture Partners. The public website healthgenetech.com redirects to www.hgt.cn.

Color Health (founded as Color Genomics in 2015) is a population health technology company that operates a nationwide, oncologist-led Virtual Cancer Clinic and delivers population-scale precision health programs - hereditary cancer and cardiovascular genetic testing, pharmacogenomics, cancer early detection and screening, and clinical care…

Berry Genomics (Beijing Berry and Kang Biotechnology Co., Ltd., 贝瑞基因) is a Chinese genomics and genetic-testing company operating across reproductive health screening, hereditary disease detection, tumor and cancer diagnostics, laboratory solutions, sequencing equipment and reagents, and genomic big-data services.

Probably Genetic is a healthcare company focused on rare disease diagnosis through genetic testing. It offers free targeted genetic testing programs for specific rare conditions (including alpha-mannosidosis, cerebrotendinous xanthomatosis, GRN-FTD, and SYNGAP1-related disorder), insurance-billed testing paired with genetic counselors, at-home…